CRP and metabolic dysfunction-associated steatotic liver disease: Meanwhile, patients without NAFLD and critical COVID-19 had higher serum concentrations of CRP (127 mg/L, IQR 75–202 vs. 89 mg/L, IQR 32–122; p = 0.016), procalcitonin (0.17 μg/L, IQR 0.11–0.28 vs. 0.09, IQR 0.06–0.12; p = 0.006), and LDH (511 IU/L, IQR 419–620 vs. 284, IQR 236–445; p = 0.012).